Genomic Characterization of Circulating Dengue Virus, Ethiopia, 2022-2023. [PDF]
Abera A +25 more
europepmc +1 more source
Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3. [PDF]
Ahmadi K +3 more
europepmc +1 more source
Kelleni's protocol incorporating non-steroidal anti-inflammatory drugs and nitazoxanide to early manage dengue virus disease: An antiviral silver bullet. [PDF]
Kelleni MT.
europepmc +1 more source
Applications and insights from continuous dengue virus infection in a stable cell line. [PDF]
Morwitzer MJ +3 more
europepmc +1 more source
Analysis of RNA Binding by the Dengue Virus NS5 RNA Capping Enzyme
Brittney Henderson +3 more
openalex +2 more sources
Single VLP lipid-mixing measurements confirm off-pathway state in dengue virus fusion mechanism. [PDF]
Anika TK +7 more
europepmc +1 more source
Dynamics and genetic variation of dengue virus serotypes circulating during the 2022 outbreak in Karachi. [PDF]
Tariq F +7 more
europepmc +1 more source
Protective envelope dimer epitope-like antibodies are elicited against dengue virus in children after infection and vaccination. [PDF]
Mpingabo PI +14 more
europepmc +1 more source
Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study. [PDF]
Vats P +6 more
europepmc +1 more source

